Nefopam for acute pain in rheumatology patients
Part of Bones, joints & muscles, Pain clinical trials.
This trial tests how the body processes nefopam (a painkiller) in patients with acute musculoskeletal pain. It aims to find the right dose for managing pain during a hospital stay.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are hospitalized in a rheumatology unit.
- You have acute pain in your muscles or bones.
- Your hospital stay is expected to last at least 4 more days.
- Your pain level is 3 or more on a 0-10 scale.
- You are between 18 and 75 years old.
- If you are a woman of childbearing age, you must use highly effective birth control and have a negative pregnancy test.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a personalized medication plan can help patients with short-term, non-cancer muscle or joint pain need strong opioid medicine for a shorter time. It’s aimed at improving how long treatment lasts while still managing pain.
This trial tests a nebulized (inhaled mist) form of fentanyl in healthy volunteers to see how it works in the body. It is a first-in-human study of the drug given through a nebulizer, which might help people with acute pain in the future.
This trial tests whether adding nefopam to standard pain medicine (paracetamol and ketoprofen) improves pain control after hip replacement. It looks at both short-term and long-term effects to see if this combination helps patients recover with less pain.
This Phase 2 study tests whether oral nefopam can reduce pain after total knee replacement done with spinal anesthesia. It looks at whether this medicine works better than the usual post-surgery pain plan and how safely it can be used.
This trial tests if giving a steady dose of a painkiller called nefopam through an IV can help manage pain after a Whipple procedure (pancreatoduodenectomy). It aims to see if this approach reduces the need for other pain medications and improves recovery.
This trial tests how a new combination of oxycodone and nafamostat works in the body. It is for healthy volunteers aged 18 to 55 to help understand the drug's safety and how it is processed.
Hear when a new Acute Rheumatic Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.